Structural basis of fatty acid substrate binding to cyclooxygenase-2.
The cyclooxygenases (COX-1 and COX-2) are membrane-associated heme-containing homodimers that generate prostaglandin H(2) from arachidonic acid (AA). Although AA is the preferred substrate, other fatty acids are oxygenated by these enzymes with varying efficiencies. We determined the crystal structures of AA, eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA) bound to Co(3+)-protoporphyrin IX-reconstituted murine COX-2 to 2.1, 2.4, and 2.65 A, respectively. AA, EPA, and docosahexaenoic acid bind in different conformations in each monomer constituting the homodimer in their respective structures such that one monomer exhibits nonproductive binding and the other productive binding of the substrate in the cyclooxygenase channel. The interactions identified between protein and substrate when bound to COX-1 are conserved in our COX-2 structures, with the only notable difference being the lack of interaction of the carboxylate of AA and EPA with the side chain of Arg-120. Leu-531 exhibits a different side chain conformation when the nonproductive and productive binding modes of AA are compared. Unlike COX-1, mutating this residue to Ala, Phe, Pro, or Thr did not result in a significant loss of activity or substrate binding affinity. Determination of the L531F:AA crystal structure resulted in AA binding in the same global conformation in each monomer. We speculate that the mobility of the Leu-531 side chain increases the volume available at the opening of the cyclooxygenase channel and contributes to the observed ability of COX-2 to oxygenate a broad spectrum of fatty acid and fatty ester substrates.
Vecchio
Alex J
AJ
Hauptman-Woodward Medical Research Institute, Buffalo, New York 14203, USA.
Simmons
Danielle M
DM
Malkowski
Michael G
MG
D019943:Amino Acid Substitution / Q000235:genetics; D000818:Animals; D016718:Arachidonic Acid / Q000737:chemistry / Q000378:metabolism; D018360:Crystallography, X-Ray; D051546:Cyclooxygenase 2 / Q000737:chemistry* / Q000378:metabolism*; D004281:Docosahexaenoic Acids / Q000737:chemistry / Q000378:metabolism; D015118:Eicosapentaenoic Acid / Q000737:chemistry / Q000378:metabolism; D005227:Fatty Acids / Q000737:chemistry* / Q000378:metabolism*; D007930:Leucine / Q000378:metabolism; D051379:Mice; D008958:Models, Molecular; D008968:Molecular Conformation; D050505:Mutant Proteins / Q000737:chemistry / Q000378:metabolism; D010100:Oxygen / Q000378:metabolism; D013329:Structure-Activity Relationship; D013379:Substrate Specificity
D005227:Fatty Acids; D050505:Mutant Proteins; D004281:Docosahexaenoic Acids; D016718:Arachidonic Acid; D015118:Eicosapentaenoic Acid; C077623:Ptgs2 protein, mouse; D051546:Cyclooxygenase 2; D007930:Leucine; D010100:Oxygen
J Biol Chem. 1999 Jun 11;274(24):17109-14
10358065
FASEB J. 2006 Jun;20(8):1097-108
16770009
J Biol Chem. 2009 Apr 10;284(15):10046-55
19218248
J Biol Chem. 2002 Jan 4;277(1):478-85
11677234
Prostaglandins Other Lipid Mediat. 2002 Aug;68-69:129-52
12432914
J Biol Chem. 1992 Jun 15;267(17):12387-92
1601897
J Biol Chem. 2004 Oct 8;279(41):42929-35
15292194
Arch Biochem Biophys. 2000 Mar 1;375(1):195-200
10683267
Biochemistry. 2009 Dec 29;48(51):12233-41
19928795
Biochemistry. 2006 Mar 14;45(10):3189-205
16519514
Proc Natl Acad Sci U S A. 2006 Apr 18;103(16):6142-7
16606823
Methods Enzymol. 1997;277:620-33
18488327
Arch Biochem Biophys. 2000 Aug 1;380(1):39-45
10900130
Acta Crystallogr D Biol Crystallogr. 2006 Apr;62(Pt 4):439-50
16552146
Biochem Biophys Res Commun. 2002 Aug 23;296(3):612-7
12176025
J Biol Chem. 1995 Aug 18;270(33):19330-6
7642610
Biochemistry. 2006 Mar 14;45(10):3206-18
16519515
J Biol Chem. 1999 Aug 13;274(33):23305-10
10438506
Nature. 1996 Dec 19-26;384(6610):644-8
8967954
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2288-94
15572783
Acta Crystallogr D Biol Crystallogr. 2006 Jan;62(Pt 1):72-82
16369096
J Biol Chem. 2001 Oct 5;276(40):37547-55
11477109
J Mol Biol. 2008 Apr 18;378(1):1-11
18353365
J Biol Chem. 2000 Oct 27;275(43):33744-9
10931854
Acta Crystallogr D Biol Crystallogr. 1997 May 1;53(Pt 3):240-55
15299926
Science. 2000 Sep 15;289(5486):1933-7
10988074
Prog Lipid Res. 2007 Mar;46(2):108-25
17316818
Nucleic Acids Res. 2007 Jul;35(Web Server issue):W375-83
17452350
Acta Crystallogr D Biol Crystallogr. 1998 Sep 1;54(Pt 5):905-21
9757107
Acta Crystallogr D Biol Crystallogr. 2004 Aug;60(Pt 8):1355-63
15272157
Prostaglandins Other Lipid Mediat. 2002 Aug;68-69:95-114
12432912
J Biol Chem. 1996 Jan 26;271(4):2179-84
8567676
Chem Rev. 2003 Jun;103(6):2239-304
12797830
J Clin Invest. 2001 Jun;107(12):1491-5
11413152
Nat Protoc. 2008;3(7):1171-9
18600222
Annu Rev Biochem. 2000;69:145-82
10966456
Nature. 2000 May 4;405(6782):97-101
10811226
J Biol Chem. 1994 May 6;269(18):13207-15
8175750
J Struct Biol. 2003 Apr;142(1):170-9
12718929
Structure. 2009 Aug 12;17(8):1042-50
19679084
Acta Crystallogr D Biol Crystallogr. 2001 Jan;57(Pt 1):122-33
11134934
J Biol Chem. 2000 Mar 3;275(9):6586-91
10692466
J Biol Chem. 2004 Feb 6;279(6):4404-14
14594816
J Lipid Res. 2009 Apr;50 Suppl:S29-34
18952571
Trends Biochem Sci. 2008 Jan;33(1):27-37
18155912
J Biol Chem. 2007 Aug 3;282(31):22254-66
17519235
Acta Crystallogr D Biol Crystallogr. 2008 Jan;64(Pt 1):49-60
18094467
J Lipid Res. 2009 Apr;50 Suppl:S423-8
19095631
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
15572765
J Biol Chem. 2001 Aug 10;276(32):30072-7
11402053
J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674
19461840
J Biol Chem. 2003 Nov 14;278(46):45763-9
12925531
J Biol Chem. 2001 Mar 30;276(13):10358-65
11121413
Biochem Biophys Res Commun. 2005 Dec 9;338(1):25-33
16115608
J Biol Chem. 1993 Aug 25;268(24):18234-42
8349699
J Biol Chem. 2001 Mar 30;276(13):10347-57
11121412